Breaking News, Collaborations & Alliances

CCRM Enters Regenerative Medicine Partnerships

Signs agreements with Canadian and international institutions to advance regenerative medicine inventions.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies, is partnering with several Canadian and international institutions to advance regenerative medicine inventions, including: McGill University, McMaster University, University of Calgary and Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Canada, and Australia’s Monash University and Starfish Innovations, a subsidiary of Leiden University Medical Center, in the N...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters